Reverse rate dependency is an intrinsic property of canine cardiac preparations.
暂无分享,去创建一个
Antonio Zaza | László Virág | András Varró | Balázs Horváth | L. Virág | A. Varró | T. Bányász | J. Magyar | P. Nanasi | A. Zaza | János Magyar | Tamás Bányász | Norbert Szentandrássy | B. Horváth | S. Marangoni | László Bárándi | Péter P Nánási | G. Harmati | Gábor Harmati | Stefano Marangoni | L. Bárándi | N. Szentandrássy
[1] A. Varró,et al. Comparison of the cellular electrophysiological characteristics of canine left ventricular epicardium, M cells, endocardium and Purkinje fibres. , 1998, Acta physiologica Scandinavica.
[2] W. Trautwein,et al. Ionic currents contributing to the action potential in single ventricular myocytes of the guinea pig studied with action potential clamp , 1990, Pflügers Archiv.
[3] Y Rudy,et al. Early afterdepolarizations in cardiac myocytes: mechanism and rate dependence. , 1995, Biophysical journal.
[4] E. Ritz,et al. Diabetes – renal function – what are the special problems? , 1998, Basic Research in Cardiology.
[5] C Antzelevitch,et al. Larger late sodium conductance in M cells contributes to electrical heterogeneity in canine ventricle. , 2001, American journal of physiology. Heart and circulatory physiology.
[6] A. Jednákovits,et al. Electrophysiological effects of bimoclomol in canine ventricular myocytes , 2000, Naunyn-Schmiedeberg's Archives of Pharmacology.
[7] B. Katzung,et al. Antiarrhythmic agents: the modulated receptor mechanism of action of sodium and calcium channel-blocking drugs. , 1984, Annual review of pharmacology and toxicology.
[8] Antonio Zaza,et al. Rate dependency of delayed rectifier currents during the guinea‐pig ventricular action potential , 2001, The Journal of physiology.
[9] C. Starmer,et al. Blockade of Cardiac Sodium Channels by Lidocaine Single-Channel Analysis , 1989, Circulation research.
[10] Gergely Szabo,et al. Apico-basal inhomogeneity in distribution of ion channels in canine and human ventricular myocardium. , 2005, Cardiovascular research.
[11] C. January,et al. A Model for Early Afterdepolarizations: Induction With the Ca2+ Channel Agonist Bay K 8644 , 1988, Circulation research.
[12] D. Roden,et al. Extracellular potassium modulation of drug block of IKr. Implications for torsade de pointes and reverse use-dependence. , 1996, Circulation.
[13] B. Hille,et al. Veratridine modifies open sodium channels , 1988, The Journal of general physiology.
[14] Craig T. January,et al. Early Afterdepolarizations: Mechanism of Induction and Block A Role for L‐Type Ca2+ Current , 1989, Circulation research.
[15] S Nattel,et al. Effects of the chromanol 293B, a selective blocker of the slow, component of the delayed rectifier K+ current, on repolarization in human and guinea pig ventricular myocytes. , 1998, Cardiovascular research.
[16] B. Hille,et al. Voltage-dependent gating of veratridine-modified Na channels , 1986, The Journal of general physiology.
[17] M. Sanguinetti,et al. Rate-dependent prolongation of cardiac action potentials by a methanesulfonanilide class III antiarrhythmic agent. Specific block of rapidly activating delayed rectifier K+ current by dofetilide. , 1993, Circulation research.
[18] A. Varró,et al. The combined electrophysiological effects of lignocaine and sotalol in canine isolated cardiac Purkinje fibres are rate‐dependent , 1990, British journal of pharmacology.
[19] Antonio Zaza,et al. Pathophysiology and pharmacology of the cardiac "late sodium current.". , 2008, Pharmacology & therapeutics.
[20] Balázs Horváth,et al. Contribution of IKr and IK1 to ventricular repolarization in canine and human myocytes: is there any influence of action potential duration? , 2008, Basic Research in Cardiology.
[21] C. Starmer,et al. Phasic ion channel blockade. A kinetic model and parameter estimation procedure. , 1985, Molecular pharmacology.
[22] X. Zong,et al. Relation between veratridine reaction dynamics and macroscopic Na current in single cardiac cells , 1992, The Journal of general physiology.
[23] C. Antzelevitch,et al. Antiarrhythmic Effects of Ranolazine in a Guinea Pig in Vitro Model of Long-QT Syndrome , 2004, Journal of Pharmacology and Experimental Therapeutics.
[24] A. Bril,et al. Combined potassium and calcium channel antagonistic activities as a basis for neutral frequency dependent increase in action potential duration: comparison between BRL-32872 and azimilide. , 1998, Cardiovascular research.
[25] T. Bíró,et al. Asymmetrical distribution of ion channels in canine and human left-ventricular wall: epicardium versus midmyocardium , 2005, Pflügers Archiv.
[26] D. Snyders,et al. Class III antiarrhythmic agents have a lot of potential but a long way to go. Reduced effectiveness and dangers of reverse use dependence. , 1990, Circulation.
[27] András Varró,et al. Action potential duration and force-frequency relationship in isolated rabbit, guinea pig and rat cardiac muscle , 2004, Journal of Comparative Physiology B.
[28] A. Varró,et al. Sotalol and Mexiletine: Combination of Rate‐Dependent Electrophysiological Effects , 1990, Journal of cardiovascular pharmacology.
[29] P. Mátyus,et al. Novel antiarrhythmic compounds with combined class IB and class III mode of action. , 2004, Current medicinal chemistry.
[30] J. Weirich,et al. Rate-dependence of antiarrhythmic and proarrhythmic properties of class I and class III antiarrhythmic drugs , 1998, Basic Research in Cardiology.
[31] T. Campbell. Kinetics of onset of rate-dependent effects of Class I antiarrhythmic drugs are important in determining their effects on refractoriness in guinea-pig ventricle, and provide a theoretical basis for their subclassification. , 1983, Cardiovascular research.
[32] T. Bányász,et al. Contribution of IKs to ventricular repolarization in canine myocytes , 2006, Pflügers Archiv.
[33] A. Hux. MEASUREMENT OF CURRENT-VOLTAGE RELATIONS IN THE MEMBRANE OF THE GIANT AXON OF LOLIGO , 2006 .
[34] A. V. van Ginneken,et al. Long‐QT syndrome‐related sodium channel mutations probed by the dynamic action potential clamp technique , 2006, The Journal of physiology.
[35] B. Katzung,et al. Time- and voltage-dependent interactions of antiarrhythmic drugs with cardiac sodium channels. , 1977, Biochimica et biophysica acta.
[36] A. Grant,et al. Emerging Class III Antiarrhythmic Agents:Mechanism of Action and Proarrhythmic Potential , 1997, Cardiovascular Drugs and Therapy.